MedDataX Logo

Effect of Intermittent Hypoxia in Healthy Individuals

NCT ID: NCT04691518

Last Updated: 2023-11-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-11-16

Study Completion Date

2024-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The use of acute intermittent hypoxia (AIH) has been examined in animal and human studies to gain an understanding of its effect on spinal excitability and synaptic strength. Subsequently, the investigators have learned that the use of AIH results in new protein formation and spinal plasticity. The use of acute intermittent hypoxia demonstrates a potential for therapeutic utilization in individuals with neurologic injuries. However, little is known about the effect of AIH in healthy individuals. This work is necessary to understand the mechanisms of AIH-induced plasticity. As such, this research study seeks to evaluate the impact of a single session AIH on upper extremity motor function in healthy individuals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The use of acute intermittent hypoxia (AIH), has been demonstrated, through human and animal studies, to be an effective way of increasing spinal motor excitability and strengthening residual synaptic connectivity. AIH utilizes short duration (\<2 min) exposures to reduced oxygen levels (\~10% inspired oxygen), with alternating exposures to air with normal oxygen levels (\~21% inspired oxygen).

Previous publications demonstrate that AIH is a safe and effective intervention to modify motor function in individual with chronic incomplete spinal cord injuries. The use of AIH has been shown to influence the activation in musculature, within 60-120 minutes of administration. In addition, when coupling AIH with overground gait training, an increase in functional endurance, as evaluated through the 6 minute walk test, and gait speed, as evaluated through the 10 meter walk test, were demonstrated. In addition, the use of hypoxic training has been studied in healthy individuals and athletes; however, literature examining the effect of a single bout of AIH on performance is limited.

Although AIH has proven to be a promising treatment in enhancing spinal excitability and strengthening existing synaptic connections within individuals with chronic spinal cord injuries, further examination also needs to be made on the impact of AIH on motor function in healthy individuals.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Participants will participate in any of the interventions
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Outcome Assessors
Outcomes assessor will be blinded to Treatment or Placebo treatment when applicable

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acute Intermittent Hypoxia (AIH)

Undergoing Acute Intermittent Hypoxia sessions

Group Type ACTIVE_COMPARATOR

Acute Intermittent Hypoxia

Intervention Type OTHER

30 minute session of Acute Intermittent Hypoxia

Sham AIH

Undergoing Sham AIH sessions

Group Type PLACEBO_COMPARATOR

Sham Acute Intermittent Hypoxia

Intervention Type OTHER

30 minute session of Sham Acute Intermittent Hypoxia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acute Intermittent Hypoxia

30 minute session of Acute Intermittent Hypoxia

Intervention Type OTHER

Sham Acute Intermittent Hypoxia

30 minute session of Sham Acute Intermittent Hypoxia

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* No history of neurologic injury or progressive neuromuscular disorder
* Individuals ages 18-70 years old
* Must be medically stable with no history of cardiovascular instability, congestive heart failure or stroke
* Not currently (\>2 weeks) on any medications related to spasticity
* No history of Sleep apnea
* Not a current smoker
* Able to comply with protocol/study requirements

Exclusion Criteria

* Recent change in the use of narcotic, anti-inflammatory or pain medication
* unstable medical conditions or any other clinical observation that may affect the candidate's performance, health, safety or the ability to participate in the study determined by the treating therapist or coordinating staff
* Active participation in another movement research study or therapy program
* Anti-spasticity drug injection less than 3 months prior to beginning treatment
* Musculoskeletal pain that interferes with participation in study
* Women who are currently, may be, or planning on becoming pregnant
* for fMRI participation, participants will be excluded if they have:
* Metal fragments in eyes or face
* Implantation of any electronic devices such as (but not limited to) cardiac pacemakers, cardiac defibrillators, cochlea implants, or nerve stimulators
* Vascular surgery
* Claustrophobia
* Body piercing or tattoos
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shirley Ryan AbilityLab

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zev Rymer

Director Sensory Motor Performance Program

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

William Rymer, PhD

Role: PRINCIPAL_INVESTIGATOR

Shirley Ryan AbilityLab

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shirley Ryan AbilityLab

Chicago, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STU00202448

Identifier Type: -

Identifier Source: org_study_id